MedPath
NMPA Approval

Compound Paracetamol and Chlorphenamine Maleate Granules

国药准字H51023296

April 15, 2020

Drug Information

复方氨酚那敏颗粒

颗粒剂

复方

化学药品

April 15, 2020

Company Information

Applicant Company

Manufacturing Company

四川省眉山市青神县兴业路4号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨酚那敏颗粒 - NMPA 批准文号 | MedPath